Pathstone Holdings LLC reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 10.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,404 shares of the company’s stock after selling 3,657 shares during the quarter. Pathstone Holdings LLC’s holdings in Acadia Healthcare were worth $1,991,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Russell Investments Group Ltd. grew its position in Acadia Healthcare by 9.7% during the first quarter. Russell Investments Group Ltd. now owns 9,876 shares of the company’s stock valued at $782,000 after acquiring an additional 875 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Acadia Healthcare by 2.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,093 shares of the company’s stock worth $10,545,000 after purchasing an additional 2,584 shares during the last quarter. Cetera Advisors LLC purchased a new stake in Acadia Healthcare during the first quarter valued at about $540,000. Thompson Investment Management Inc. grew its stake in shares of Acadia Healthcare by 18.9% during the second quarter. Thompson Investment Management Inc. now owns 6,285 shares of the company’s stock valued at $424,000 after buying an additional 1,000 shares during the last quarter. Finally, Harbor Capital Advisors Inc. purchased a new position in shares of Acadia Healthcare in the second quarter worth about $800,000.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on ACHC shares. KeyCorp began coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Royal Bank of Canada lowered their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $79.67.
Acadia Healthcare Stock Performance
Shares of ACHC opened at $41.03 on Wednesday. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77. The company has a 50-day simple moving average of $53.36 and a two-hundred day simple moving average of $64.32. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market capitalization of $3.81 billion, a PE ratio of 13.45, a price-to-earnings-growth ratio of 1.69 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 earnings per share. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- The How and Why of Investing in Gold Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.